Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma.

Xiaoshuang KongXudong ZhangMengjie DingXiaoyan FengMeng DongLei ZhangXiaorui FuLing LiXin LiZhenchang SunJiaqin YanXinhua WangXiaolong WuQingjiang ChenMingzhi ZhangLinan Zhu

Published in: Cancer medicine (2023)

The decitabine-RDHAP regimen is effective and well tolerated, and is a promising salvage regimen for R/R-DLBCL.

Keyphrases

diffuse large b cell lymphoma
acute myeloid leukemia
epstein barr virus
acute lymphoblastic leukemia
multiple myeloma